FDA wants to pull decongestant found in many cold, allergy medicines
The FDA is proposing the removal of phenylephrine, a popular nasal decongestant, in oral form from over-the-counter use. Here ...
TipRanks on MSN1d
TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks for the Rest of 2024
With the end of 2024 approaching, what could be more natural than to figure out the top stocks for the rest of the year?
Merck & Co., Inc. (MRK): Among the Best Low Volatility Stocks to Invest In Now
We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...
SHINE1d
German companies express strong confidence in Chinese economy
German companies including Merck and ZEISS expressed strong confidence and high hopes for the Chinese market at the China ...
While the mood outside was dour, attendees at the annual Pennsylvania Conference for Women gamely tried to stick to the program
Green’s sister, Ragine Williams, 30, does DEI reporting, recruiting, and outreach for the technology firm SEI. She agreed that coming together with other women was inspiring, even if some may have ...
Merck Says Winrevair Recommended for Reimbursement in Canada
Merck & Co. said Friday that Canada's Drug Agency recommended the company's Winrevair for reimbursement as a treatment for adults with pulmonary arterial hypertension. The agency recommended the ...
Canada's Drug Agency Recommends WINREVAIR® (sotatercept) for Reimbursement
Sotatercept is the first activin signaling inhibitor therapy for PAH in Canada, a new class of therapy that works by improving the balance between pro-proliferative and anti-proliferative signaling to ...
MM&M2d
Post-election prescription: Why Trump’s return could disrupt pharma
From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...
Ban Lemsip because 'it doesn't work', say experts after US health chiefs propose pulling cold and flu remedies from chemist shelves
Yesterday, US health officials proposed getting rid of oral drugs containing the decongestant phenylephrine over concerns ...
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...
FiercePharma2d
Daiichi Sankyo links up with Korea's Alteogen on subcutaneous Enhertu in $300M licensing deal
A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...